S

SensaSure Technologies Inc
OTC:FOMI

Watchlist Manager
SensaSure Technologies Inc
OTC:FOMI
Watchlist
Price: 0.0001 USD
Market Cap: $40k

SensaSure Technologies Inc
Investor Relations

SensaSure Technologies, Inc. operates as a medical company, which engages in developing, validating, and commercializing a product intended to transform the way biological samples are collected for analysis. The company is headquartered in New York City, New York. The firm is engaged in supplying a device and method to collect a breath sample for lab-based analysis. The firm's method is known as ExaBreath (EB) and it can collect, extract, detect and identify non-volatile compounds present in every exhaled breath by utilizing existing lab-based testing infrastructure and procedures. EB is applicable in toxicology, pharmacology, and clinical biochemistry. EB enhances the user experience in a range of applications and markets, such as workplace drug testing, anti-doping in sports, law enforcement, e-health, and telemedicine. The firm's testing methodology is a non-invasive way to collect chemicals in breath, for disease detection, exposure monitoring, and drug metabolism. EB detects a range of exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics), and performance-enhancing drugs used in sports (stimulants), as well as many other compounds.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Scott A. Cox
President, CEO, CFO & Director
No Bio Available

Contacts

Address
NEW YORK
New York City
505 Park Avenue, 4th Floor
Contacts
+13473254677
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett